A study published in April 2017 in Journal of Bone and Mineral Research provides reassuring information about the short-term and long-term safety of denosumab, a monoclonal antibody that is used to treat postmenopausal osteoporosis. A release from the publisher explains that the study showed that adverse events that had been noted in a pivotal clinical… Continue reading Osteoporosis Drug Found Safe in Long-Term Trial